Global health groups reached out to the Medicines Control Council (MCC) in South Africa Thursday advocating “compassionate use” of an exploratory multidrug-resistant tuberculosis (MDR-TB) treatment known as TMC-207 or bedaquiline. The compassionate use concept allows patients access to promising new drug candidates in clinical trials when current treatment options have proven unsuccessful and is endorsed […]